Corrigendum to “Coronavirus Disease-19: The First 7,755 Cases in the Republic of Korea” [Osong Public Health Res Perspect 2020;11(2):85–90]

Article information

Osong Public Health Res Perspect. 2020;11(3):146-146
COVID-19 National Emergency Response Center, Epidemiology and Case Management Team, Korea Centers for Disease Control and Prevention
Korea Centers for Disease Control and Prevention, Cheongju, Korea
*Corresponding author: COVID-19 National Emergency Response Center, Epidemiology and Case Management Team, Korea Centers for Disease Control and Prevention, Cheongju, Korea, E-mail: jeongek@korea.kr
This corrects the article "Coronavirus Disease-19: The First 7,755 Cases in the Republic of Korea" in Volume 11 on page 85.

In the above-mentioned article, the authors want to update the errors in Results and Table 3, specifically the errors in the percentages and the subheadings with clearer meaning. The authors regret this error and would like to apologize for any inconvenience caused.

Fatal cases (n = 66) of laboratory-confirmed COVID -19 cases, as of March 12th 2020, Republic of Korea.

In the result section, “Of 63 cases, 96.8% were reported to have comorbidities: 47.6% hypertension, 36.5% diabetes, 16% neurodegenerative disorders, and 17.5% pulmonary diseases.” should be changed to: “Of 66 cases, 92.4% were reported to have comorbidities: 45.4% hypertension, 34.8% diabetes, 24.2% neurodegenerative disorders, and 16.7% pulmonary diseases”.

The results related to fatal cases in Table 3 should be changed as follows.

Article information Continued

Table 3

Fatal cases (n = 66) of laboratory-confirmed COVID -19 cases, as of March 12th 2020, Republic of Korea.

Variables n (%)
Age, years, median (range) 77 (35–93)

Sex
 Female 29 (43.9)
 Male 37 (56.1)

Coexisting condition*
 Any 61 (92.4)
  Cerebrovascular disease 5 (7.6)
  Heart disease 10 (15.2)
  Pulmonary disease 11 (16.7)
  Kidney disease 5 (7.6)
  Diabetes 23 (34.8)
  Hypertension 30 (45.4)
  Cancer 7 (10.6)
  Neurodegenerative disorder 16 (24.2)
 Under investigation 5 (7.6)

Region
 Daegu 47 (71.2)
 Gyeongbuk 16 (24.2)
 Others 3 (4.5)

Death before admission 5 (7.6)
Interval, days, median (range)
 Symptom → Death 10 (1–24)
 Symptom → Diagnosis 4 (0–20)
 Symptom → Hospitalization 4.5 (0–11)
 Hospitalization → Death 5 (0–16)

Total 66
*

A single case may have multiple comorbidities (investigation files required).